News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
367,977 Results
Type
Article (18381)
Company Profile (305)
Press Release (349285)
Multimedia
Podcasts (116)
Webinars (11)
Section
Business (104743)
Career Advice (409)
Deals (19719)
Drug Delivery (52)
Drug Development (59741)
Employer Resources (42)
FDA (8105)
Job Trends (7154)
News (188591)
Policy (14268)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1166)
Accelerated approval (24)
Adcomms (20)
Allergies (102)
Alliances (26982)
ALS (149)
Alzheimer's disease (1165)
Antibody-drug conjugate (ADC) (295)
Approvals (8349)
Artificial intelligence (324)
Autoimmune disease (124)
Automation (11)
Bankruptcy (183)
Best Places to Work (6328)
BIOSECURE Act (7)
Biosimilars (120)
Biotechnology (235)
Bladder cancer (118)
Brain cancer (49)
Breast cancer (499)
Cancer (3874)
Cardiovascular disease (274)
Career advice (346)
Career pathing (12)
CAR-T (250)
CDC (13)
Celiac Disease (1)
Cell therapy (632)
Cervical cancer (24)
Clinical research (51569)
Collaboration (1327)
Company closure (2)
Compensation (664)
Complete response letters (47)
COVID-19 (1489)
CRISPR (87)
C-suite (636)
Cystic fibrosis (132)
Data (5175)
Decentralized trials (1)
Denatured (52)
Depression (107)
Diabetes (299)
Diagnostics (2922)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (12)
Drug discovery (209)
Drug pricing (73)
Drug shortages (6)
Duchenne muscular dystrophy (224)
Earnings (46246)
Editorial (32)
Employer branding (5)
Employer resources (41)
Events (62765)
Executive appointments (717)
FDA (10395)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1103)
Gene editing (189)
Generative AI (24)
Gene therapy (525)
GLP-1 (586)
Government (1535)
Grass and pollen (3)
Guidances (293)
Healthcare (8846)
HIV (23)
Huntington's disease (45)
IgA nephropathy (79)
Immunology and inflammation (200)
Immuno-oncology (43)
Indications (81)
Infectious disease (1627)
Inflammatory bowel disease (165)
Inflation Reduction Act (10)
Influenza (58)
Intellectual property (209)
Interviews (82)
IPO (10873)
IRA (18)
Job creations (1146)
Job search strategy (288)
JPM (50)
Kidney cancer (12)
Labor market (37)
Layoffs (290)
Leadership (11)
Legal (2394)
Liver cancer (59)
Longevity (11)
Lung cancer (546)
Lymphoma (290)
Machine learning (28)
Management (13)
Manufacturing (452)
MASH (148)
Medical device (5327)
Medtech (5354)
Mergers & acquisitions (9726)
Metabolic disorders (837)
Multiple sclerosis (128)
NASH (14)
Neurodegenerative disease (260)
Neuropsychiatric disorders (76)
Neuroscience (2209)
Neurotech (1)
NextGen: Class of 2026 (2696)
Non-profit (1129)
Now hiring (33)
Obesity (376)
Opinion (149)
Ovarian cancer (149)
Pain (141)
Pancreatic cancer (182)
Parkinson's disease (248)
Partnered (19)
Patents (388)
Patient recruitment (393)
Peanut (45)
People (32205)
Pharmaceutical (46)
Pharmacy benefit managers (27)
Phase 1 (17636)
Phase 2 (23637)
Phase 3 (15827)
Pipeline (4095)
Policy (132)
Postmarket research (1069)
Preclinical (7433)
Press Release (45)
Prostate cancer (180)
Psychedelics (50)
Radiopharmaceuticals (258)
Rare diseases (729)
Real estate (1917)
Recruiting (19)
Regulatory (13368)
Reports (23)
Research institute (1219)
Resumes & cover letters (51)
Rett syndrome (27)
RNA editing (21)
RSV (26)
Schizophrenia (135)
Series A (193)
Series B (145)
Service/supplier (3)
Sickle cell disease (91)
Special edition (20)
Spinal muscular atrophy (127)
Sponsored (20)
Startups (2151)
State (1)
Stomach cancer (11)
Supply chain (51)
Tariffs (19)
The Weekly (63)
Vaccines (503)
Venture capital (73)
Weight loss (193)
Women's health (47)
Worklife (7)
Date
Today (6)
Last 7 days (417)
Last 30 days (1599)
Last 365 days (22332)
2026 (2056)
2025 (22622)
2024 (25890)
2023 (28620)
2022 (33636)
2021 (35257)
2020 (30940)
2019 (21728)
2018 (15951)
2017 (18109)
2016 (15269)
2015 (18758)
2014 (13777)
2013 (9993)
2012 (10272)
2011 (10710)
2010 (10304)
Location
Africa (232)
Alabama (66)
Alaska (3)
Arizona (113)
Arkansas (6)
Asia (23340)
Australia (3762)
California (8545)
Canada (2549)
China (921)
Colorado (329)
Connecticut (345)
Delaware (256)
Europe (49505)
Florida (1170)
Georgia (256)
Hawaii (2)
Idaho (24)
Illinois (492)
India (44)
Indiana (236)
Iowa (13)
Japan (340)
Kansas (84)
Kentucky (14)
Louisiana (16)
Maine (54)
Maryland (964)
Massachusetts (6477)
Michigan (165)
Minnesota (322)
Mississippi (3)
Missouri (77)
Montana (23)
Nebraska (5)
Nevada (84)
New Hampshire (52)
New Jersey (2129)
New Mexico (20)
New York (2216)
North Carolina (1041)
North Dakota (6)
Northern California (4129)
Ohio (189)
Oklahoma (12)
Oregon (26)
Pennsylvania (1560)
Puerto Rico (18)
Rhode Island (26)
South America (420)
South Carolina (51)
Southern California (3425)
Tennessee (54)
Texas (1236)
United States (28877)
Utah (160)
Virginia (181)
Washington D.C. (40)
Washington State (703)
West Virginia (1)
Wisconsin (53)
367,977 Results for "expression therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Expression Therapeutics Appoints Industry Veteran Dr. David Townson as Chief Executive Officer
December 10, 2025
·
3 min read
Press Releases
Akari Therapeutics Files Key Patent and Unveils Second ADC Program AKTX-102 Targeting CEACAM5 Expressing Solid Tumors
January 27, 2026
·
9 min read
Press Releases
A2 Biotherapeutics Announces FDA Clearance of IND for A2B543 for Treatment of Adults with Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors that Express Mesothelin and Have Lost HLA-A*02 Expression
January 9, 2026
·
5 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
Press Releases
Whitehawk Therapeutics Presents Real-World Analysis Confirming PTK7 as a Broadly Expressed, Clinically Relevant Target Across Solid Tumors at AACR-NCI-EORTC
October 27, 2025
·
6 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Accord BioPharma’s HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies
January 5, 2026
·
8 min read
Press Releases
GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF
January 29, 2026
·
8 min read
Press Releases
Independent Sinovac Shareholders Express Strong Support for Immediate Dividend Payment
November 11, 2025
·
2 min read
Press Releases
New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology’s Evorpacept in Combination with Ziihera (zanidatamab-hrii) in Advanced HER2-Positive Breast Cancer
February 1, 2026
·
4 min read
1 of 36,798
Next
